These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 23829775)

  • 1. Kidney transplantation with positive complement-dependent lymphocytotoxicity crossmatch with negative flow crossmatching and Luminexx donor-specific antibodies.
    Kute VB; Vanikar AV; Gumber MR; Trivedi VB; Shah PR; Patel HV; Balwani MR; Modi PR; Trivedi HL
    Ren Fail; 2013 Aug; 35(7):1027-30. PubMed ID: 23829775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic flow cytometric crossmatch in renal transplantation: a single assay to simultaneously detect antibody binding and cytotoxicity.
    Thammanichanond D; Athimang W; Paisooksantivatana K; Mongkolsuk T; Ingsathit A; Worawichawong S; Kitpoka P; Jirasiritham S; Kantachuvesiri S
    Transplant Proc; 2012 Jan; 44(1):62-5. PubMed ID: 22310580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study between cytotoxicity and flowcytometry crossmatches before and after renal transplantation.
    Abdel Rahman AS; Fahim NM; El Sayed AA; El Hady SA; Ahmad YS
    Egypt J Immunol; 2005; 12(2):77-89. PubMed ID: 17977213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crossmatching technique facilitating kidney transplantation.
    Buabut B; Chiewsilp P; Patanapanyasat K; Jirasiritham S; Mavichak V; Sujirachato K; Mongkolsuk T
    J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S55-61. PubMed ID: 9347647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor kidney allograft survival associated with positive B cell - Only flow cytometry cross matches: a ten year single center study.
    Norin AJ; Mondragon-Escorpizo MO; Brar A; Hochman D; Sumrani N; Distant DA; Salifu MO
    Hum Immunol; 2013 Oct; 74(10):1304-12. PubMed ID: 23811689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
    Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN
    Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation with positive complement-dependent microcytotoxicity crossmatch in contemporary kidney transplantation: Practice patterns and associated outcomes.
    Graff RJ; Xiao H; Duffy B; Schnitzler MA; Axelrod D; Lentine KL
    Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):234-45. PubMed ID: 22382213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing number of laboratories performing complement dependent cytotoxicity crossmatching: Reasons and conclusions.
    Putheti P; Liwski RS; Jindra PT
    Hum Immunol; 2022 May; 83(5):467-475. PubMed ID: 35183390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
    Tait BD; Süsal C; Gebel HM; Nickerson PW; Zachary AA; Claas FH; Reed EF; Bray RA; Campbell P; Chapman JR; Coates PT; Colvin RB; Cozzi E; Doxiadis II; Fuggle SV; Gill J; Glotz D; Lachmann N; Mohanakumar T; Suciu-Foca N; Sumitran-Holgersson S; Tanabe K; Taylor CJ; Tyan DB; Webster A; Zeevi A; Opelz G
    Transplantation; 2013 Jan; 95(1):19-47. PubMed ID: 23238534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
    Vlad G; Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
    Hum Immunol; 2009 Aug; 70(8):589-94. PubMed ID: 19375470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
    Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement-dependent cytotoxicity crossmatch in solid organ transplantation: The gold standard or golden history?
    Tafulo S; Osório E; Mendes C; Liwski R
    Hum Immunol; 2024 Jan; 85(1):110734. PubMed ID: 38030522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human leukocyte antigen antibody-incompatible renal transplantation: excellent medium-term outcomes with negative cytotoxic crossmatch.
    Higgins R; Lowe D; Hathaway M; Williams C; Lam FT; Kashi H; Tan LC; Imray C; Fletcher S; Chen K; Krishnan N; Hamer R; Daga S; Edey M; Zehnder D; Briggs D
    Transplantation; 2011 Oct; 92(8):900-6. PubMed ID: 21968524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of a positive flow crossmatch on the outcomes of cadaveric renal transplants.
    Ilham MA; Winkler S; Coates E; Rizzello A; Rees TJ; Asderakis A
    Transplant Proc; 2008; 40(6):1839-43. PubMed ID: 18675065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified flow cytometry crossmatch detecting alloantibody-related cytotoxicity as a way to distinguish lytic antibodies from harmless in allosensitised kidney recipients.
    Zieliński M; Zielińska H; Moszkowska G; Dȩbska-Ślizień A; Rutkowski B; Trzonkowski P
    Transplant Proc; 2013; 45(1):88-94. PubMed ID: 23375279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous detection of antibody binding and cytotoxicity in flow cytometry crossmatch for renal transplantation.
    Won DI; Jeong HD; Kim YL; Suh JS
    Cytometry B Clin Cytom; 2006 Mar; 70(2):82-90. PubMed ID: 16470535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of a flow cytometry cross-match in the setting of a negative complement-dependent cytotoxicity cross-match in heart transplant recipients.
    Keeshan BC; O'Connor MJ; Lin KY; Monos D; Lind C; Mascio CE; Rame JE; Spray TL; Shaddy RE; Rossano JW
    Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28766759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acceptable reactive crossmatch (ARC), post-transplant monitoring, and their impact on kidney transplantation: a single center experience.
    Leone JP; Bowers V; Baliga R; Sanders C; LeFor W; Becker D; Thompson D; Resto-Ruiz S; Lopez-Cepero M
    Clin Transpl; 2011; ():373-9. PubMed ID: 22755434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.